Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants and Data Collection
2.3. Measurement
2.3.1. Questionnaire Development
2.3.2. Background Characteristics
2.3.3. COVID-19 Vaccine Hesitancy for Their Children
2.3.4. Parents’ COVID-19 Vaccine Hesitancy
2.3.5. Attitudes toward COVID-19 Vaccination for Children
2.3.6. Influence of Social Media
2.4. Sample Size Planning
2.5. Statistical Analysis
3. Results
3.1. Background Characteristics
3.2. Changes in Parents’ COVID-19 Vaccine Hesitancy
3.3. Changes in Attitudes toward COVID-19 Vaccination for Children and Information Exposure on Social Media
3.4. Factors Associated with COVID-19 Vaccine Hesitancy among Parents of Children Aged 3–11 Years
3.5. Factors Associated with COVID-19 Vaccine Hesitancy among Parents of Children Aged 12–17 Years
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bhopal, S.S.; Bagaria, J.; Olabi, B.; Bhopal, R. COVID-19 deaths in children: Comparison with all- and other causes and trends in incidence of mortality. Public Health 2020, 188, 32–34. [Google Scholar] [CrossRef] [PubMed]
- Saleem, H.; Rahman, J.; Aslam, N.; Murtazaliev, S.; Khan, S. Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic Review. Cureus 2020, 12, e8207. [Google Scholar] [CrossRef] [PubMed]
- CentersforDiseaseControlandPrevention. Demographic Trends of COVID-19 Cases and Deaths in the US Reported to CDC 2022. Available online: https://covid.cdc.gov/covid-data-tracker/#demographics (accessed on 27 June 2022).
- Statista. Number of Coronavirus (COVID-19) Cases in Germany in 2022, by Age Group and Gender 2022. Available online: https://www.statista.com/statistics/1105465/coronavirus-covid-19-cases-age-group-germany/ (accessed on 27 June 2022).
- Statista. Number of the Coronavirus (COVID-19) Cases in India as of October 18, 2021, by Age Group 2022. Available online: https://www.statista.com/statistics/1110522/india-number-of-coronavirus-cases-by-age-group/ (accessed on 27 June 2022).
- Statista. Age Breakdown of People Infected with the COVID-19 Coronavirus in France as of March 15, 2020, by Situation 2022. Available online: https://www.statista.com/statistics/1102881/infections-coronavirus-age-france/ (accessed on 27 June 2022).
- The Government of Hong Kong Special Administrative Region. Coronavirus Disease (COVID-19) in HK 2022. Available online: https://chp-dashboard.geodata.gov.hk/covid-19/zh.html (accessed on 27 June 2022).
- Rasmussen, S.A.; Thompson, L.A. Coronavirus Disease 2019 and Children: What Pediatric Health Care Clinicians Need to Know. JAMA Pediatr. 2020, 174, 743–744. [Google Scholar] [CrossRef]
- Lv, M.; Luo, X.; Shen, Q.; Lei, R.; Liu, X.; Liu, E.; Li, Q.; Chen, Y. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines 2021, 9, 1102. [Google Scholar] [CrossRef]
- Tian, F.; Yang, R.; Chen, Z. Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials. J. Med. Virol. 2022, 94, 4644–4653. [Google Scholar] [CrossRef]
- Gao, P.; Cai, S.; Liu, Q.; Du, M.; Liu, J.; Liu, M. Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis. Vaccines 2022, 10, 421. [Google Scholar] [CrossRef] [PubMed]
- Sadeghi, S.; Kalantari, Y.; Shokri, S.; Fallahpour, M.; Nafissi, N.; Goodarzi, A.; Valizadeh, R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2–21 years old: A Systematic Review and Meta-analysis. J. Clin. Virol. 2022, 153, 105196. [Google Scholar] [CrossRef]
- Walter, E.B.; Talaat, K.R.; Sabharwal, C.; Gurtman, A.; Lockhart, S.; Paulsen, G.C.; Barnett, E.D.; Muñoz, F.M.; Maldonado, Y.; Pahud, B.A.; et al. Evaluation of the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age. N. Engl. J. Med. 2022, 386, 35–46. [Google Scholar] [CrossRef]
- Woodworth, K.R.; Moulia, D.; Collins, J.P.; Hadler, S.C.; Jones, J.M.; Reddy, S.C.; Chamberland, M.; Campos-Outcalt, D.; Morgan, R.L.; Brooks, O.; et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years—United States, November 2021. MMWR Morb. Mortal Wkly. Rep. 2021, 70, 1579–1583. [Google Scholar] [CrossRef]
- Hause, A.M.; Baggs, J.; Marquez, P.; Abara, W.E.; Olubajo, B.; Myers, T.R.; Su, J.R.; Thompson, D.; Gee, J.; Shimabukuro, T.T.; et al. Safety Monitoring of COVID-19 Vaccine Booster Doses among Persons Aged 12–17 Years—United States, December 9, 2021–February 20, 2022. MMWR Morb. Mortal Wkly. Rep. 2022, 71, 347–351. [Google Scholar] [CrossRef]
- Hause, A.M.; Gee, J.; Baggs, J.; Abara, W.E.; Marquez, P.; Thompson, D.; Su, J.R.; Licata, C.; Rosenblum, H.G.; Myers, T.R.; et al. COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years—United States, December 14, 2020–July 16, 2021. MMWR Morb. Mortal Wkly. Rep. 2021, 70, 1053–1058. [Google Scholar] [CrossRef] [PubMed]
- Oster, M.E.; Shay, D.K.; Su, J.R.; Gee, J.; Creech, C.B.; Broder, K.R.; Edwards, K.; Soslow, J.H.; Dendy, J.M.; Schlaudecker, E.; et al. Myocarditis Cases Reported after mRNA-Based COVID-19 Vaccination in the US from December 2020 to August 2021. JAMA 2022, 327, 331–340. [Google Scholar] [CrossRef] [PubMed]
- Jafari, S.; Chan, K.; Aboulhosn, K.; Yip, B.; Lima, V.D.; Hogg, R.S.; Montaner, J.; Moore, D.M. Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: An observational study. AIDS Res. Ther. 2011, 8, 31. [Google Scholar] [CrossRef] [PubMed]
- Brown-Jacobsen, A.M.; Wallace, D.P.; Whiteside, S.P. Multimethod, multi-informant agreement, and positive predictive value in the identification of child anxiety disorders using the SCAS and ADIS-C. Assessment 2011, 18, 382–392. [Google Scholar] [CrossRef] [PubMed]
- Industry Pulse. High blood pressure & cardiovascular prevention. Off. J. Ital. Soc. Hypertens. 2005, 12, 195–198. [Google Scholar]
- Shenzhen Municipal Health Commission. Frequent Answers and Questions about the Implementation of COVID-19 Vaccines for Children Aged 3–11 Years Old in 2021. Available online: http://wjw.sz.gov.cn/yqxx/content/post_9299120.html (accessed on 1 August 2022).
- Blanchard, E.B.; Gerardi, R.J.; Kolb, L.C.; Barlow, D.H. The utility of the Anxiety Disorders Interview Schedule (ADIS) in the diagnosis of post-traumatic stress disorder (PTSD) in Vietnam veterans. Behav. Res. Ther. 1986, 24, 577–580. [Google Scholar] [CrossRef]
- Hope, D.A.; Laguna, L.B.; Heimberg, R.G.; Barlow, D.H. Relationship between ADIS clinician’s severity rating and self-report measures among social phobics. Depress. Anxiety 1996, 4, 120–125. [Google Scholar] [CrossRef]
- Di Nardo, P.; Moras, K.; Barlow, D.H.; Rapee, R.M.; Brown, T.A. Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch. Gen. Psychiatry 1993, 50, 251–256. [Google Scholar] [CrossRef]
- Chen, F.; He, Y.; Shi, Y. Parents’ and Guardians’ Willingness to Vaccinate Their Children against COVID-19: A Systematic Review and Meta-Analysis. Vaccines 2022, 10, 179. [Google Scholar] [CrossRef]
- Galanis, P.; Vraka, I.; Siskou, O.; Konstantakopoulou, O.; Katsiroumpa, A.; Kaitelidou, D. Willingness, refusal and influential factors of parents to vaccinate their children against the COVID-19: A systematic review and meta-analysis. Prev. Med. 2022, 157, 106994. [Google Scholar] [CrossRef]
- Wang, Q.; Xiu, S.X.; Zhao, S.Y.; Wang, J.L.; Han, Y.; Dong, S.H.; Huang, J.; Cui, T.; Yang, L.; Shi, N.; et al. Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study. Vaccines 2021, 9, 342. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; She, R.; Chen, X.; Li, L.; Li, L.; Huang, Z.; Lau, J. Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: A cross-sectional online survey. Hum. Vacc. Immunother. 2021, 17, 3322–3332. [Google Scholar] [CrossRef]
- Xu, Y.; Zhang, R.; Zhou, Z.; Fan, J.; Liang, J.; Cai, L.; Peng, L.; Ren, F.; Lin, W. Parental psychological distress and attitudes towards COVID-19 vaccination: A cross-sectional survey in Shenzhen, China. J. Affect. Disord. 2021, 292, 552–558. [Google Scholar] [CrossRef] [PubMed]
- Feng, H.Y.F.; Zhu, H.; Zhang, H.J.; Cao, L.S.; Li, L.; Wang, J.H.; Huang, Y.; Lai, X.; Lyu, Y.; Jing, R.; et al. Caregivers’ intentions to COVID-19 vaccination for their children in China: A cross-sectional survey. Hum. Vacc. Immunother. 2021, 17, 4799–4805. [Google Scholar] [CrossRef] [PubMed]
- Du, M.; Tao, L.; Liu, J. The Association between Risk Perception and COVID-19 Vaccine Hesitancy for Children among Reproductive Women in China: An Online Survey. Front. Med. 2021, 8, 1494. [Google Scholar] [CrossRef] [PubMed]
- Wan, X.; Huang, H.T.; Shang, J.; Xie, Z.X.; Jia, R.Y.; Lu, G.L.; Chen, C. Willingness and influential factors of parents of 3–6-year-old children to vaccinate their children with the COVID-19 vaccine in China. Hum. Vacc. Immunother. 2021, 17, 3969–3974. [Google Scholar] [CrossRef]
- Wu, L.; Huang, Z.; Guo, X.; Liu, J.; Sun, X. Measuring parents’ acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China. Hum. Vaccin. Immunother. 2022, 18, 2069427. [Google Scholar] [CrossRef]
- Zhang, M.X.; Lin, X.Q.; Chen, Y.; Tung, T.H.; Zhu, J.S. Determinants of parental hesitancy to vaccinate their children against COVID-19 in China. Expert Rev. Vaccines 2021, 20, 1339–1349. [Google Scholar] [CrossRef]
- Xu, Y.; Xu, D.; Luo, L.; Ma, F.; Wang, P.; Li, H.; Li, Q.; Wei, L.; Diao, J.; Liu, Y.; et al. A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy among Parents from Shandong vs. Zhejiang. Front. Public Health 2021, 9, 779720. [Google Scholar] [CrossRef]
- Wu, J.; Zhao, L.P.; Wang, M.Y.; Gu, J.Q.; Wei, W.; Li, Q.M.; Ma, M.; Mu, Z.; Miao, Y. Guardians’ willingness to vaccinate their teenagers against COVID-19 in China: A national cross-sectional survey. J. Affect. Disord. 2022, 299, 196–204. [Google Scholar] [CrossRef]
- Ma, L.B.; Yang, J.; Zhang, T.; Han, X.; Huang, Q.R.; Yang, Y.; Feng, L.; Yang, W.; Wang, C. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: A cross-sectional study on the guardians of children in China. Hum. Vacc. Immunother. 2022, 18, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Li, T.; Qiu, X.C.; Gong, X.; Zhan, R.; Zheng, X.J. The cross-sectional survey on COVID-19 vaccine hesitancy and it predictors among Chinese parents of 3–17 years aged children in Shenzhen City. Ann. Agric. Environ. Med. 2022, 29, 120–125. [Google Scholar] [CrossRef] [PubMed]
- Qin, C.Y.; Wang, R.T.; Tao, L.Y.; Liu, M.; Liu, J. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children among Child Caregivers in China. Front. Public Health 2022, 10, 834572. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.Q.; Zhou, X.; Wang, Z. Parental Acceptability of COVID-19 Vaccination for Children under the Age of 18 Years: Cross-Sectional Online Survey. JMIR Pediatrics Parent. 2020, 3, e24827. [Google Scholar] [CrossRef] [PubMed]
- Loomba, S.; de Figueiredo, A.; Piatek, S.J.; de Graaf, K.; Larson, H.J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 2021, 5, 337–348. [Google Scholar] [CrossRef]
- Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef]
- Huang, X.; Yu, M.; Fu, G.; Lan, G.; Li, L.; Yang, J.; Qiao, Y.; Zhao, J.; Qian, H.Z.; Zhang, X.; et al. Willingness to receive COVID-19 vaccination among people living with HIV and AIDS in China: A nationwide cross-sectional online survey. JMIR Public Health Surveill. 2021, 7, e31125. [Google Scholar] [CrossRef]
- Tram, K.H.; Saeed, S.; Bradley, C.; Fox, B.; Eshun-Wilson, I.; Mody, A.; Geng, E. Deliberation, Dissent, and Distrust: Understanding Distinct Drivers of Coronavirus Disease 2019 Vaccine Hesitancy in the United States. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2022, 74, 1429–1441. [Google Scholar] [CrossRef]
- Daly, M.; Jones, A.; Robinson, E. Public Trust and Willingness to Vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021. JAMA 2021, 325, 2397–2399. [Google Scholar] [CrossRef]
- Xiao, J.; Cheung, J.K.; Wu, P.; Ni, M.Y.; Cowling, B.J.; Liao, Q. Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys. Lancet Reg. Health West. Pac. 2022, 23, 100441. [Google Scholar] [CrossRef]
- Zhang, K.; Fang, Y.; Chan, P.S.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers. Int. J. Environ. Res. Public Health 2022, 19, 5245. [Google Scholar] [CrossRef] [PubMed]
- Zhang, K.C.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; Zhou, X.; Wang, Z. Behavioral Intention to Receive a COVID-19 Vaccination among Chinese Factory Workers: Cross-sectional Online Survey. J. Med. Internet Res. 2021, 23, e24673. [Google Scholar] [CrossRef] [PubMed]
- Commerce Bureau of Shenzhen Municipality. Longhua District. Available online: http://commerce.sz.gov.cn/tzly/qyfb/gqcyjs/content/post_8571905.html (accessed on 18 January 2022).
- Pan, Y.; Fang, Y.; Xin, M.; Dong, W.; Zhou, L.; Hou, Q.; Li, F.; Sun, G.; Zheng, Z.; Yuan, J.; et al. Self-Reported Compliance with Personal Preventive Measures among Chinese Factory Workers at the Beginning of Work Resumption Following the COVID-19 Outbreak: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22457. [Google Scholar] [CrossRef]
- Pan, Y.; Xin, M.; Zhang, C.; Dong, W.; Fang, Y.; Wu, W.; Li, M.; Pang, J.; Zheng, Z.; Wang, Z.; et al. Associations of Mental Health and Personal Preventive Measure Compliance with Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study. J. Med. Internet Res. 2020, 22, e22596. [Google Scholar] [CrossRef]
- Yuan, J.; Cao, B.; Zhang, C.; Chan, P.S.; Xin, M.; Fang, Y.; Chen, Y.; Huang, D.; Li, L.; Xuan, X.; et al. Changes in Compliance With Personal Preventive Measures and Mental Health Status among Chinese Factory Workers during the COVID-19 Pandemic: An Observational Prospective Cohort Study. Front. Public Health 2022, 10, 831456. [Google Scholar] [CrossRef] [PubMed]
- Bagateli, L.E.; Saeki, E.Y.; Fadda, M.; Agostoni, C.; Marchisio, P.; Milani, G.P. COVID-19 vaccine hesitancy among parents of children and adolescents living in Brazil. Vaccines 2021, 9, 1115. [Google Scholar] [CrossRef]
- Brandstetter, S.; Böhmer, M.M.; Pawellek, M.; Seelbach-Göbel, B.; Melter, M.; Kabesch, M.; Apfelbacher, C.; KUNO-Kids Study Group. Parents’ intention to get vaccinated and have their child vaccinated against COVID-19: Cross-sectional analyses using data from the KUNO-Kids health study. Eur. J. Pediatrics 2021, 180, 3405–3410. [Google Scholar] [CrossRef]
- Lecce, M.; Milani, G.P.; Agostoni, C.; D’Auria, E.; Banderali, G.; Biganzoli, G.; Castellazzi, L.; Paramithiotti, C.; Salvatici, E.; Tommasi, P.; et al. Caregivers’ intention to vaccinate their children under 12 years of age against COVID-19: A cross-sectional multicenter study in Milan, Italy. Front. Pediatrics 2022, 10, 834363. [Google Scholar] [CrossRef]
- Whelan, S.O.; Moriarty, F.; Lawlor, L.; Gorman, K.M.; Beamish, J. Vaccine hesitancy and reported non-vaccination in an Irish pediatric outpatient population. Eur. J. Pediatric 2021, 180, 2839–2847. [Google Scholar] [CrossRef]
- Suran, M. Why Parents Still Hesitate to Vaccinate Their Children against COVID-19. JAMA 2022, 327, 23–25. [Google Scholar] [CrossRef]
- Bayart, J.L.; Douxfils, J.; Gillot, C.; David, C.; Mullier, F.; Elsen, M.; Eucher, C.; Van Eeckhoudt, S.; Roy, T.; Gerin, V.; et al. Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines 2021, 9, 1092. [Google Scholar] [CrossRef] [PubMed]
- Yue, L.; Xie, T.; Yang, T.; Zhou, J.; Chen, H.; Zhu, H.; Li, H.; Xiang, H.; Wang, J.; Yang, H.; et al. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine. J. Med. Virol. 2022, 94, 35–38. [Google Scholar] [CrossRef]
- Choi, A.; Koch, M.; Wu, K.; Chu, L.; Ma, L.; Hill, A.; Nunna, N.; Huang, W.; Oestreicher, J.; Colpitts, T.; et al. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: An interim analysis. Nat. Med. 2021, 27, 2025–2031. [Google Scholar] [CrossRef] [PubMed]
- Huang, X.; Yan, Y.; Su, B.; Xiao, D.; Yu, M.; Jin, X.; Duan, J.; Zhang, X.; Zheng, S.; Fang, Y.; et al. Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China. Viruses 2022, 14, 277. [Google Scholar] [CrossRef] [PubMed]
- Levin, E.G.; Lustig, Y.; Cohen, C.; Fluss, R.; Indenbaum, V.; Amit, S.; Doolman, R.; Asraf, K.; Mendelson, E.; Ziv, A.; et al. Waning Immune Humoral Response to BNT162b2 COVID-19 Vaccine over 6 Months. N. Engl. J. Med. 2021, 385, e84. [Google Scholar] [CrossRef] [PubMed]
- Katz, S.E.; Edwards, K. Protecting Children against Omicron. JAMA 2022, 327, 2195–2197. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention (CDC). COVID-19 Vaccine Recommendations for Children and Teens. Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccines-children-teens.html (accessed on 25 July 2022).
- NHS Coronavirus (COVID-19) Vaccine for Children Aged 5 to 15. Available online: https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-covid-19-vaccination-for-children/coronavirus-covid-19-vaccine-for-children-aged-5-to-15/ (accessed on 25 July 2022).
- The Government of the Hong Kong SAR. COVID-19 Vaccination Programme. Available online: https://www.covidvaccine.gov.hk/en/programme (accessed on 1 March 2021).
- Yap, S.F.; Lim, W.M.; Gaur, S.S.; Lim, P.Y. A framework for preventive health marketing. J. Strateg. Mark. 2021, 1–24. [Google Scholar] [CrossRef]
- McMenamin, M.E.; Nealon, J.; Lin, Y.; Wong, J.Y.; Cheung, J.K.; Lau, E.H.Y.; Wu, P.; Leung, G.M.; Cowling, B.J. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: A population-based observational study. Lancet Infect. Diseases. 2022. [Google Scholar] [CrossRef]
- Buonsenso, D.; Valentini, P.; Macchi, M.; Folino, F.; Pensabene, C.; Patria, M.F.; Agostoni, C.; Castaldi, S.; Lecce, M.; Giannì, M.L.; et al. Caregivers’ Attitudes toward COVID-19 Vaccination in Children and Adolescents With a History of SARS-CoV-2 Infection. Front. Pediatr. 2022, 10, 867968. [Google Scholar] [CrossRef]
- Fu, L.; Wang, B.; Chan, P.S.F.; Luo, D.; Zheng, W.; Ju, N.; Hu, Y.; Xiao, X.; Xu, H.; Yang, X.; et al. Associations between COVID-19 related stigma and sleep quality among COVID-19 survivors six months after hospital discharge. Sleep Med. 2022, 91, 273–281. [Google Scholar] [CrossRef]
- Ju, N.; Yang, X.; Ma, X.; Wang, B.; Fu, L.; Hu, Y.; Luo, D.; Xiao, X.; Zheng, W.; Xu, H.; et al. Hospitalization, interpersonal and personal factors of social anxiety among COVID-19 survivors at the six-month follow-up after hospital treatment: The minority stress model. Eur. J. Psychotraumatol. 2022, 13, 2019980. [Google Scholar] [CrossRef] [PubMed]
- Lim, W.M.; Weissmann, M.A. Toward a theory of behavioral control. J. Strateg. Mark. 2021, 1–27. [Google Scholar] [CrossRef]
Measurements | Round 1 | Round 2 |
---|---|---|
Sociodemographic characteristics | ||
Age | √ | √ |
Gender | √ | √ |
Relationship status | √ | √ |
Education level | √ | √ |
Monthly personal income, CNY (USD) | √ | √ |
Type of work | √ | √ |
Personal COVID-19 preventive measures in the past month | ||
Frequency of face mask wearing in public spaces or on transportation other than in the workplace | √ | √ |
Frequency of face mask wearing when you have close contact with other people in the workplace | √ | √ |
Frequency of sanitizing of hands by using soaps, liquid soaps, or alcohol-based sanitizer after returning from public spaces or touching public installations | √ | √ |
Self-reported avoidance of social and meal gatherings with other people who do not live together | √ | √ |
Self-reported avoiding of crowded places | √ | √ |
COVID-19 vaccination uptake and hesitancy | ||
Number of doses of COVID-19 vaccination received by their children | ⅹ | √ |
Likelihood of letting their children be given a COVID-19 vaccination 1 | √ | √ |
Perceptions related to COVID-19 vaccination | ||
Positive attitudes | ||
COVID-19 vaccination is highly effective in protecting your child from COVID-19 | √ | √ |
COVID-19 vaccination can contribute to the control of COVID-19 in China | √ | √ |
China will have an adequate supply of COVID-19 vaccines | √ | √ |
Negative attitudes | √ | √ |
Your child will have severe side effects after receiving a COVID-19 vaccination | √ | √ |
The protection of COVID-19 vaccines will only last for a short time | √ | √ |
Your child is afraid of vaccination | √ | √ |
You do not have time to take your child for a COVID-19 vaccination | √ | √ |
Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in letting the child be given a COVID-19 vaccination | √ | √ |
Perceived behavioral control to let the child be given a COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to | √ | √ |
Frequency of exposure to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||
Experiences related to COVID-19 vaccination shared by recipients on social media | √ | √ |
The COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | ⅹ | √ |
Infectiousness and harms of the variants of concern of SARS-CoV-2 | ⅹ | √ |
Outbreaks caused by variants of concern of SARS-CoV-2 in some places in China | ⅹ | √ |
People develop COVID-19 after receiving a primary series of COVID-19 | ⅹ | √ |
Characteristics | Parents of Children Aged 3–11 Years | Parents of Children Aged 12–17 Years | ||||
---|---|---|---|---|---|---|
Round 1 (n = 590) | Round 2 (n = 873) | Round 1 (n = 254) | Round 2 (n = 340) | |||
n (%) | n (%) | p-Values 1 | n (%) | n (%) | p-Values 1 | |
Sociodemographic characteristics | ||||||
Age, years, mean (SD) | ||||||
34.8 (5.3) | 35.5 (5.1) | 0.01 | 41.7 (4.7) | 40.7 (5.2) | 0.01 | |
Gender | ||||||
Male | 236 (40.0) | 387 (44.3) | 69 (27.2) | 148 (43.5) | ||
Female | 354 (60.0) | 486 (57.9) | 0.10 | 185 (72.8) | 192 (56.5) | <0.001 |
Relationship status | ||||||
Married | 564 (95.6) | 836 (95.8) | 238 (93.7) | 328 (96.5) | ||
Single or divorced | 24 (4.1) | 32 (3.7) | 16 (6.3) | 11 (3.2) | ||
Having a stable partner | 2 (0.3) | 5 (0.6) | 0.76 | 0 (0.0) | 1 (0.3) | 0.15 |
Education level | ||||||
Senior high or below | 443 (75.1) | 464 (53.2) | 215 (84.6) | 204 (60.0) | ||
College and above | 147 (24.9) | 409 (46.8) | <0.001 | 39 (15.4) | 136 (40.0) | <0.001 |
Monthly personal income, CNY (USD) | ||||||
<3000 (462) | 128 (21.7) | 93 (10.7) | 61 (24.0) | 47 (13.8) | ||
3000–6999 (462–1077) | 365 (61.9) | 531 (60.8) | 173 (68.1) | 202 (59.4) | ||
≥7000 (1078) | 97 (16.4) | 249 (28.5) | <0.001 | 20 (7.9) | 91 (26.8) | <0.001 |
Type of work | ||||||
Frontline workers | 390 (66.1) | 537 (61.5) | 179 (70.5) | 226 (66.5) | ||
Management staff | 200 (33.9) | 336 (38.5) | 0.07 | 75 (29.5) | 114 (33.5) | 0.30 |
Personal COVID-19 preventive measures in the past month | ||||||
Frequency of face mask wearing in public spaces or on transportation other than in the workplace | ||||||
Every time | 495 (83.9) | 746 (85.5) | 210 (82.7) | 261 (76.8) | ||
Often | 78 (13.2) | 101 (11.6) | 32 (12.6) | 64 (18.8) | ||
Sometimes | 17 (2.9) | 26 (3.0) | 12 (4.7) | 14 (4.1) | ||
Never | 0 (0.0) | 0 (0.0) | 0.64 | 0 (0.0) | 1 (0.3) | 0.17 |
Frequency of face mask wearing when you have close contact with other people in the workplace | ||||||
Every time | 416 (70.5) | 643 (73.7) | 224 (88.2) | 302 (88.8) | ||
Often | 127 (21.5) | 160 (18.3) | 27 (10.6) | 32 (9.4) | ||
Sometimes | 45 (7.6) | 62 (7.1) | 3 (1.2) | 6 (1.8) | ||
Never | 2 (0.3) | 8 (0.9) | 0.24 | 0 (0.0) | 0 (0.0) | 0.76 |
Frequency of sanitizing of hands by using soaps, liquid soaps, or alcohol-based sanitizer after returning from public spaces or touching public installations | ||||||
Every time | 352 (41.4) | 484 (55.4) | 154 (60.6) | 190 (55.9) | ||
Often | 155 (26.3) | 206 (23.6) | 69 (27.2) | 88 (25.9) | ||
Sometimes | 87 (14.7) | 165 (18.9) | 28 (11.0) | 53 (15.6) | ||
Never | 6 (1.0) | 18 (2.1) | 0.06 | 3 (1.2) | 6 (2.6) | 0.22 |
Self-reported avoidance of social and meal gatherings with other people who do not live together | ||||||
No | 241 (40.8) | 362 (41.5) | 107 (42.1) | 139 (40.9) | ||
Yes | 349 (59.2) | 511 (58.5) | 0.81 | 147 (57.9) | 201 (59.1) | 0.76 |
Self-reported avoidance of crowded places | ||||||
No | 205 (34.7) | 293 (33.6) | 78 (30.7) | 119 (34.7) | ||
Yes | 385 (65.3) | 580 (66.4) | 0.64 | 176 (69.3) | 222 (65.3) | 0.31 |
Round 1 (n = 590) | Round 2 (n = 873) | OR (95% CI) p-Value | AOR (95% CI) p-Value | |
---|---|---|---|---|
COVID-19 vaccination uptake and hesitancy | ||||
Number of doses of COVID-19 vaccination received by their children, n (%) | ||||
0 | 0 (0.0) | 761 (87.2) | ||
1 | 0 (0.0) | 37 (4.2) | ||
2 | 0 (0.0) | 75 (8.6) | N.A. | N.A. |
COVID-19 vaccine hesitancy for their children, n (%) | ||||
No | 437 (74.1) | 721 (82.6) | 0.60 (0.47, 0.78) | 0.57 (0.44, 0.75) |
Yes | 153 (25.9) | 152 (17.4) | p < 0.001 | p < 0.001 |
COVID-19 vaccine hesitancy among parents, n (%) | ||||
No | 466 (79.0) | 864 (99.0) | 0.04 (0.02, 0.08) | 0.04 (0.02, 0.09) |
Yes | 124 (21.0) | 9 (1.0) | p < 0.001 | p < 0.001 |
Attitudes toward COVID-19 vaccination for their children | ||||
Positive attitudes toward COVID-19 vaccination, n (%) agree | ||||
COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 334 (56.6) | 614 (70.3) | 1.82 (1.46, 2.26) p < 0.001 | 1.76 (1.41, 2.21) p < 0.001 |
COVID-19 vaccination can contribute to the control of COVID-19 in China | 507 (85.9) | 808 (92.6) | 2.04 (1.44, 2.87) p < 0.001 | 1.75 (1.23, 2.50) p = 0.002 |
China will have an adequate supply of COVID-19 vaccines | 432 (73.2) | 788 (90.3) | 3.39 (2.54, 4.53) p < 0.001 | 2.94 (2.18, 3.96) p < 0.001 |
Positive Attitude Scale score, mean (SD) | 8.1 (1.2) | 8.5 (0.9) | B (95% CI) 0.39 (0.28, 0.50), p < 0.001 | Adjusted B (95% CI) 0.34 (0.23, 0.45), p < 0.001 |
Negative attitudes toward COVID-19 vaccination, n (%) agree | ||||
Your child will have severe side effects after receiving a COVID-19 vaccination | 44 (7.5) | 131 (15.0) | 2.19 (1.53, 3.14) p < 0.001 | 2.26 (1.56, 3.27) p < 0.001 |
The protection of COVID-19 vaccines will only last for a short time | 116 (19.7) | 430 (49.3) | 3.97 (3.11, 5.06) p < 0.001 | 4.06 (3.16, 5.22) p < 0.001 |
Your child is afraid of vaccination | 118 (20.0) | 206 (23.6) | 1.24 (0.96, 1.59) p = 0.10 | 1.24 (0.95, 1.62) p = 0.11 |
You do not have time to take your child for a COVID-19 vaccination | 138 (23.4) | 250 (28.6) | 1.31 (1.03, 1.67) p = 0.03 | 1.43 (1.11, 1.83) p = 0.005 |
Negative Attitude Scale score, mean (SD) | 7.7 (1.6) | 8.0 (1.9) | B (95% CI) 0.29 (0.10, 0.47), p = 0.003 | Adjusted B (95% CI) 0.35 (0.15, 0.54), p < 0.001 |
Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in letting the child be given a COVID-19 vaccination | ||||
Agree, n (%) | 300 (50.8) | 615 (70.4) | 2.30 (1.85, 2.86) p < 0.001 | 2.25 (1.79, 2.82) p < 0.001 |
Response score, mean (SD) | 2.5 (0.6) | 2.6 (0.6) | B (95% CI) 0.18 (0.12, 0.24), p < 0.001 | Adjusted B (95% CI) 0.17 (0.11, 0.23), p < 0.001 |
Perceived behavioral control to let the child be given a COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to | ||||
Agree, n (%) | 260 (44.1) | 589 (67.5) | 2.63 (2.12, 3.27) p < 0.001 | 2.43 (1.94, 3.04) p < 0.001 |
Response score, mean (SD) | 2.3 (0.7) | 2.6 (0.6) | B (95% CI) 0.27 (0.21, 0.34), p < 0.001 | Adjusted B (95% CI) 0.24 (0.17, 0.31), p < 0.001 |
Frequency of exposure to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||
Experiences related to COVID-19 vaccination shared by recipients on social media, n (%) | ||||
Almost none | 278 (47.1) | 199 (22.8) | ||
Seldom | 156 (26.4) | 299 (34.2) | ||
Sometimes | 106 (18.0) | 261 (29.9) | ||
Always | 50 (8.5) | 114 (13.1) | ||
Response score, mean (SD) | 1.9 (1.0) | 2.3 (1.0) | B (95% CI) 0.45 (0.35, 0.56), p < 0.001 | Adjusted B (95% CI) 0.47 (0.37, 0.58), p < 0.001 |
The COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | ||||
Almost none | 182 (20.8) | |||
Seldom | 271 (31.0) | |||
Sometimes | 261 (29.9) | |||
Always | N.A. | 159 (18.2) | ||
Response score, mean (SD) | N.A. | 2.5 (1.0) | N.A. | N.A. |
Infectiousness and harms of the variants of concern of SARS-CoV-2 | ||||
Almost none | 114 (13.1) | |||
Seldom | 217 (24.9) | |||
Sometimes | 280 (32.1) | |||
Always | N.A. | 262 (30.0) | ||
Response score, mean (SD) | N.A. | 2.8 (1.0) | N.A. | N.A. |
Outbreaks caused by variants of concern of SARS-CoV-2 in some places in China | ||||
Almost none | 130 (14.9) | |||
Seldom | 293 (33.6) | |||
Sometimes | 298 (34.1) | |||
Always | N.A. | 152 (17.4) | ||
Response score, mean (SD) | N.A. | 2.5 (0.9) | N.A. | N.A. |
People develop COVID-19 after receiving the primary series of COVID-19 vaccinations | ||||
Almost none | 181 (20.7) | |||
Seldom | 385 (44.1) | |||
Sometimes | 237 (27.1) | |||
Always | N.A. | 70 (8.0) | ||
Response score, mean (SD) | N.A. | 2.2 (0.9) | N.A. | N.A. |
Round 1 (n = 254) | Round 2 (n = 340) | OR (95% CI) p-Value | AOR (95% CI) p-Value | |
---|---|---|---|---|
COVID-19 vaccination uptake and hesitancy | ||||
Number of doses of COVID-19 vaccination received by their children, n (%) | ||||
0 | 0 (0.0) | 49 (14.4) | ||
1 | 0 (0.0) | 31 (9.1) | ||
2 | 0 (0.0) | 260 (76.5) | N.A. | N.A. |
COVID-19 vaccine hesitancy for their children, n (%) | ||||
No | 188 (74.0) | 328 (96.5) | 0.10 (0.06, 0.20) | 0.10 (0.05, 0.20) |
Yes | 66 (26.0) | 12 (3.5) | p < 0.001 | p < 0.001 |
COVID-19 vaccine hesitancy among parents, n (%) | ||||
No | 195 (76.8) | 337 (99.1) | 0.03 (0.01, 0.10) | 0.03 (0.01, 0.11) |
Yes | 59 (23.2) | 3 (0.9) | p < 0.001 | p < 0.001 |
Attitudes toward COVID-19 vaccination for their children | ||||
Positive attitudes toward COVID-19 vaccination, n (%) agree | ||||
COVID-19 vaccination is highly effective in protecting your child from COVID-19 | 150 (59.1) | 255 (75.0) | 2.08 (1.47, 2.95) p < 0.001 | 2.11 (1.45, 3.07) p < 0.001 |
COVID-19 vaccination can contribute to the control of COVID-19 in China | 209 (82.3) | 315 (92.6) | 2.71 (1.61, 4.56) p < 0.001 | 2.78 (1.59, 4.88) p < 0.001 |
China will have an adequate supply of COVID-19 vaccines | 170 (66.9) | 303 (89.1) | 4.05 (2.63, 6.22) p < 0.001 | 3.63 (2.29, 5.74) p < 0.001 |
Positive Attitude Scale score, mean (SD) | 7.9 (1.3) | 8.5 (0.9) | B (95% CI) 0.57 (0.39, 0.74) p < 0.001 | Adjusted B (95% CI) 0.52 (0.34, 0.71) p < 0.001 |
Negative attitudes toward COVID-19 vaccination, n (%) agree | ||||
Your child will have severe side effects after receiving a COVID-19 vaccination | 33 (13.0) | 44 (12.9) | 0.99 (0.61, 1.62) p = 0.99 | 0.97 (0.58, 1.62) p = 0.90 |
The protection of COVID-19 vaccines will only last for a short time | 49 (19.3) | 161 (47.4) | 3.76 (2.58, 5.49) p < 0.001 | 4.03 (2.70, 6.02) p < 0.001 |
Your child is afraid of vaccination | 49 (19.3) | 61 (17.9) | 0.92 (0.60, 1.39) p = 0.68 | 0.93 (0.60, 1.45) p = 0.74 |
You do not have time to take your child for a COVID-19 vaccination | 63 (24.8) | 113 (33.2) | 1.51 (1.05, 2.17) p = 0.03 | 1.50 (1.02, 2.21) p = 0.04 |
Negative Attitude Scale score, mean (SD) | 7.8 (1.6) | 7.4 (2.0) | B (95% CI) −0.40 (−0.71, −0.09), p = 0.01 | Adjusted B (95% CI) −0.39 (−0.72, −0.06), p = 0.02 |
Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in letting the child be given a COVID-19 vaccination | ||||
Agree, n (%) | 137 (53.9) | 302 (88.8) | 6.79 (4.47, 10.31) p < 0.001 | 7.09 (4.51, 11.15) p < 0.001 |
Response score, mean (SD) | 2.5 (0.6) | 2.9 (0.5) | B (95% CI) | Adjusted B (95% CI) |
0.36 (0.27, 0.44) p < 0.001 | 0.37 (0.28, 0.46) p < 0.001 | |||
Perceived behavioral control to let the child be given a COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to | ||||
Agree, n (%) | 97 (38.2) | 273 (80.3) | 6.60 (4.56, 9.53) p < 0.001 | 6.10 (4.12, 9.06) p < 0.001 |
Response score, mean (SD) | 2.3 (0.7) | 2.8 (0.5) | B (95% CI) | Adjusted B (95% CI) |
0.49 (0.40, 0.59) p < 0.001 | 0.45 (0.35, 0.55) p < 0.001 | |||
Frequency of exposure to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||
Experiences related to COVID-19 vaccination shared by recipients on social media, n (%) | ||||
Almost none | 125 (49.2) | 82 (24.1) | ||
Seldom | 55 (21.7) | 116 (34.1) | ||
Sometimes | 46 (18.1) | 101 (29.7) | ||
Always | 28 (11.0) | 41 (12.1) | ||
Response score, mean (SD) | 1.9 (1.1) | 2.3 (1.0) | B (95% CI) | Adjusted B (95% CI) |
0.39 (0.22, 0.55) p < 0.001 | 0.44 (0.27, 0.62) p < 0.001 | |||
The COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | ||||
Almost none | 53 (15.6) | |||
Seldom | 108 (31.8) | |||
Sometimes | 106 (31.2) | |||
Always | N.A. | 73 (21.5) | ||
Response score, mean (SD) | N.A. | 2.6 (1.0) | N.A. | N.A. |
Infectiousness and harms of the variants of concern of SARS-CoV-2 | ||||
Almost none | 37 (10.9) | |||
Seldom | 92 (27.1) | |||
Sometimes | 116 (34.1) | |||
Always | N.A. | 95 (27.9) | ||
Response score, mean (SD) | N.A. | 2.8 (1.0) | N.A. | N.A. |
Outbreaks caused by variants of concern of SARS-CoV-2 in some places in China | ||||
Almost none | 45 (13.2) | |||
Seldom | 128 (37.6) | |||
Sometimes | 119 (35.0) | |||
Always | N.A. | 48 (14.1) | ||
Response score, mean (SD) | N.A. | 2.5 (0.9) | N.A. | N.A. |
People develop COVID-19 after receiving primary series of COVID-19 | ||||
Almost none | 70 (20.6) | |||
Seldom | 165 (48.5) | |||
Sometimes | 86 (25.3) | |||
Always | N.A. | 19 (5.6) | ||
Response score, mean (SD) | N.A. | 2.2 (0.8) | N.A. | N.A. |
Round 1 (n = 590) | Round 2 (n = 873) | |||
---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Sociodemographic characteristics | ||||
Age, years | 1.00 (0.96, 1.03) | 0.78 | 0.96 (0.93, 1.00) | 0.051 |
Gender | ||||
Male | 1.0 | 1.0 | ||
Female | 1.13 (0.77, 1.64) | 0.54 | 0.98 (0.69, 1.39) | 0.91 |
Relationship status | ||||
Married | 1.0 | 1.0 | ||
Single or divorced | 0.74 (0.27, 2.02) | 0.56 | 0.88 (0.33, 2.33) | 0.80 |
Having a stable partner | N.A. | N.A. | 3.18 (0.53, 19.18) | 0.21 |
Education level | ||||
Senior high or below | 1.0 | 1.0 | ||
College and above | 1.09 (0.72, 1.66) | 0.68 | 1.46 (1.03, 2.07) | 0.04 |
Monthly personal income, CNY (USD) | ||||
<3000 (462) | 1.0 | 1.0 | ||
3000–6999 (462–1077) | 1.10 (0.70, 1.74) | 0.68 | 0.89 (0.50, 1.60) | 0.70 |
≥7000 (1078) | 0.70 (0.37, 1.33) | 0.28 | 1.30 (0.70, 2.42) | 0.40 |
Type of work | ||||
Frontline workers | 1.0 | 1.0 | ||
Management staff | 1.05 (0.71, 1.54) | 0.82 | 1.20 (0.84, 1.71) | 0.31 |
Personal COVID-19 preventive measures in the past month | ||||
Frequency of face mask wearing in public spaces or on transportation other than in the workplace | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.72 (0.44, 1.16) | 0.17 | 0.75 (0.47, 1.19) | 0.22 |
Frequency of face mask wearing when you have close contact with other people in the workplace | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.78 (0.53, 1.16) | 0.23 | 0.59 (0.40, 0.85) | 0.01 |
Frequency of sanitizing of hands by using soaps, liquid soaps, or alcohol-based sanitizer after returning from public spaces or touching public installations | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.91 (0.63, 1.32) | 0.61 | 0.72 (0.51, 1.02) | 0.07 |
Self-reported avoidance of social and meal gatherings with other people who do not live together | ||||
No | 1.0 | 1.0 | ||
Yes | 0.57 (0.39, 0.83) | 0.003 | 0.77 (0.54, 1.10) | 0.15 |
Self-reported avoidance of crowded places | ||||
No | 1.0 | 1.0 | ||
Yes | 0.55 (0.38, 0.80) | 0.002 | 0.76 (0.53, 1.09) | 0.13 |
Round 1 (n = 590) | Round 2 (n = 873) | |||
---|---|---|---|---|
AOR (95% CI) | p-Value | AOR (95% CI) | p-Value | |
COVID-19 vaccine hesitancy among parents | ||||
No | 1.0 | 1.0 | ||
Yes | 2.50 (1.63, 3.81) | <0.001 | 6.34 (1.66, 24.22) | 0.01 |
Attitudes toward children’s COVID-19 vaccination | ||||
Positive Attitude Scale | 0.53 (0.45, 0.63) | <0.001 | 0.48 (0.40, 0.57) | <0.001 |
Negative Attitude Scale | 1.05 (0.94, 1.19) | 0.40 | 1.11 (1.01, 1.21) | 0.03 |
Perceived subjective norm related to child’s COVID-19 vaccination | 0.21 (0.14, 0.30) | <0.001 | 0.25 (0.19, 0.33) | <0.001 |
Perceived behavioral control to let the child be given a COVID-19 vaccination | 0.57 (0.43, 0.76) | <0.001 | 0.39 (0.30, 0.50) | <0.001 |
Frequency of exposure to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||
Experiences related to COVID-19 vaccination shared by recipients on social media | 0.97 (0.80, 1.17) | 0.71 | 0.80 (0.66, 0.96) | 0.02 |
The COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | N.A. | N.A. | 0.98 (0.83, 1.17) | 0.83 |
Infectiousness and harms of the variants of concern of SARS-CoV-2 | N.A. | N.A. | 0.83 (0.70, 0.99) | 0.04 |
Outbreaks caused by variants of concern of SARS-CoV-2 in some places of China | N.A. | N.A. | 1.07 (0.88, 1.29) | 0.50 |
People develop COVID-19 after receiving a primary series of COVID-19 vaccination | N.A. | N.A. | 1.24 (1.01, 1.52) | 0.04 |
Round 1 (n = 254) | Round 2 (n = 340) | |||
---|---|---|---|---|
OR (95% CI) | p-Values | OR (95% CI) | p-Values | |
Sociodemographic characteristics | ||||
Age, years | 1.01 (0.95, 1.07) | 0.87 | 0.83 (0.75, 0.92) | 0.001 |
Gender | ||||
Male | 1.0 | 1.0 | ||
Female | 1.10 (0.58, 2.09) | 0.77 | 1.08 (0.34, 3.48) | 0.90 |
Relationship status | ||||
Married | 1.0 | 1.0 | ||
Single or divorced | 0.95 (0.29, 3.04) | 0.93 | 7.07 (1.35, 37.03) | 0.02 |
Having a stable partner | N.A. | N.A. | N.A. | N.A. |
Education level | ||||
Senior high or below | 1.0 | 1.0 | ||
College and above | 0.70 (0.30, 1.61) | 0.40 | 1.52 (0.48, 4.83) | 0.47 |
Monthly personal income, CNY (USD) | ||||
<3000 (462) | 1.0 | 1.0 | ||
3000–6999 (462–1077) | 1.11 (0.57, 2.18) | 0.76 | 0.27 (0.07, 1.06) | 0.06 |
≥7000 (1078) | 1.02 (0.32, 3.29) | 0.97 | 0.37 (0.08, 1.71) | 0.20 |
Type of work | ||||
Frontline workers | 1.0 | 1.0 | ||
Management staff | 0.95 (0.51, 1.77) | 0.88 | 0.39 (0.08, 1.79) | 0.22 |
Personal COVID-19 preventive measures in the past month | ||||
Frequency of face mask wearing in public spaces or on transportation other than in the workplace | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.30 (0.10, 0.94) | 0.04 | 0.16 (0.05, 0.52) | 0.003 |
Frequency of face mask wearing when you have close contact with other people in the workplace | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.62 (0.31, 1.25) | 0.18 | 1.53 (0.33, 7.15) | 0.59 |
Frequency of sanitizing of hands by using soaps, liquid soaps, or alcohol-based sanitizer after returning from public spaces or touching public installations | ||||
Often/sometimes/never | 1.0 | 1.0 | ||
Every time | 0.92 (0.52, 1.62) | 0.77 | 0.78 (0.25, 2.48) | 0.68 |
Self-reported avoidance of social and meal gatherings with other people who do not live together | ||||
No | 1.0 | 1.0 | ||
Yes | 0.77 (0.44, 1.35) | 0.36 | 0.97 (0.30, 3.11) | 0.96 |
Self-reported avoidance of crowded places | ||||
No | 1.0 | 1.0 | ||
Yes | 0.93 (0.51, 1.71) | 0.82 | 1.07 (0.31, 3.61) | 0.92 |
Round 1 (n = 254) | Round 2 (n = 340) | |||
---|---|---|---|---|
AOR (95% CI) | p-Values | AOR (95% CI) | p-Values | |
COVID-19 vaccine hesitancy among parents | ||||
No | 1.0 | |||
Yes | 1.59 (0.84, 3.01) | 0.15 | N.A. | N.A. |
Attitudes toward children’s COVID-19 vaccination | ||||
Positive Attitude Scale | 0.71 (0.57, 0.88) | 0.002 | 0.55 (0.34, 0.87) | 0.01 |
Negative Attitude Scale | 1.18 (0.99, 1.40) | 0.07 | 1.25 (0.95, 1.66) | 0.12 |
Perceived subjective norm related to child’s COVID-19 vaccination | 0.33 (0.20, 0.54) | <0.001 | 0.26 (0.11, 0.61) | 0.002 |
Perceived behavioral control to let the child be given a COVID-19 vaccination | 0.51 (0.33, 0.80) | 0.003 | 0.42 (0.18, 0.99) | 0.049 |
Frequency of exposure to the following information on social media (e.g., WeChat, WeChat moments, Weibo, Tiktok) in the past month | ||||
Experiences related to COVID-19 vaccination shared by recipients on social media | 1.03 (0.79, 1.34) | 0.85 | 0.62 (0.31, 1.26) | 0.19 |
The COVID-19 pandemic is not under control in some countries after scaling up COVID-19 vaccination | N.A. | N.A. | 0.59 (0.29, 1.22) | 0.15 |
Infectiousness and harms of the variants of concern of SARS-CoV-2 | N.A. | N.A. | 0.76 (0.39, 1.48) | 0.42 |
Outbreaks caused by variants of concern of SARS-CoV-2 in some places of China | N.A. | N.A. | 0.74 (0.36, 1.49) | 0.39 |
People develop COVID-19 after receiving a primary series of COVID-19 vaccination | N.A. | N.A. | 0.75 (0.34, 1.69) | 0.49 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhou, X.; Wang, S.; Zhang, K.; Chen, S.; Chan, P.S.-f.; Fang, Y.; Cao, H.; Chen, H.; Hu, T.; Chen, Y.; et al. Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys. Vaccines 2022, 10, 1478. https://doi.org/10.3390/vaccines10091478
Zhou X, Wang S, Zhang K, Chen S, Chan PS-f, Fang Y, Cao H, Chen H, Hu T, Chen Y, et al. Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys. Vaccines. 2022; 10(9):1478. https://doi.org/10.3390/vaccines10091478
Chicago/Turabian StyleZhou, Xiaofeng, Shiyu Wang, Kechun Zhang, Siyu Chen, Paul Shing-fong Chan, Yuan Fang, He Cao, Hongbiao Chen, Tian Hu, Yaqi Chen, and et al. 2022. "Changes in Parents’ COVID-19 Vaccine Hesitancy for Children Aged 3–17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys" Vaccines 10, no. 9: 1478. https://doi.org/10.3390/vaccines10091478